Treatment with radium-224

Soft tissue sarcoma - Treatment with radium-224 Factor

Last reviewed for CCPS 20 August 2008.

Preliminary questions [30648]

30651 there is some evidence that treatment with radium-224 may be a factor in the development of the condition under consideration.

30652 the veteran has received treatment with radium-224 at some time.

30656 the veteran received treatment with radium-224 as treatment for an illness or injury which is identifiable.

30653 — the veteran has established the causal connection between receiving treatment with radium-224 and VEA service for the clinical onset of soft tissue sarcoma.

30650 — the veteran has established the causal connection between receiving treatment with radium-224 and eligible service for the clinical onset of soft tissue sarcoma.

or

30649 — the veteran has established the causal connection between receiving treatment with radium-224 and operational service for the clinical onset of soft tissue sarcoma.

Clinical onset and operational service [30649]

30657

for the identified illness or injury, the veteran received treatment with radium-224 at least two years before the clinical onset of the condition under consideration.

30659 — the identified illness or injury for which treatment with radium-224 was received is causally related to operational service.

Clinical onset and eligible service [30650]

30658

for the identified illness or injury, the veteran received treatment with radium-224 at least five years before the clinical onset of the condition under consideration.

30660 — the identified illness or injury for which treatment with radium-224 was received is causally related to eligible service.